Good morning Winechemist. Your comment regarding Vyvanse totally makes sense. I'm excited about Generic Oxycontin too. I just hope after that approval they also chase SequestOx or the patented version of ADT Oxy without Naltrexone which is 90% cheaper to produce, I'm refer to below comment from Nasrat.
“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “
Thanks again Winechemist for your insight Much appreciated
Market Data 
Markets 
AI
